• HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody Workflow

  2026-09-05

  Build sensitive goat-primary detection workflows for immunofluorescence, Western blotting, flow cytometry, and tissue staining with a defined Alexa Fluor 488 signal. This guide translates the PHD2/HIF-1α/EPO findings from a high-altitude hypoxia study into practical assay design, controls, and troubleshooting decisions.

• HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody

  2026-09-04

  Build sensitive human-IgG detection workflows for immunofluorescence, Western blotting, flow cytometry, IHC, and ELISA with one Alexa Fluor 488-labeled secondary. The guide emphasizes variant-panel assay design, species matching, quantitative controls, and practical troubleshooting for translational vaccine research.

• SPP2 as a Negative Regulator of Liver Regeneration

  2026-09-04

  Lin et al. combined transcriptomic discovery with in vivo CRISPR screening to identify SPP2 as a secreted inhibitor of liver regeneration. Genetic loss of Spp2 improved recovery after liver injury, while mechanistic experiments linked its effects to BMP antagonism and interactions with integrin-family receptors.

• YC-1: From Hypoxia Biology to Translational Strategy

  2026-09-03

  YC-1 offers translational researchers a mechanistically rich way to interrogate hypoxia, soluble guanylyl cyclase signaling, tumor vascular biology, and pathway-dependent phenotypes. This article connects its established cancer research utility with emerging neuroinflammation findings while clearly distinguishing evidence from hypothesis.

• Lycopene, ERK, and DON-Induced Gut Barrier Injury

  2026-09-03

  A 2025 study in Antioxidants shows that lycopene protects porcine intestinal epithelial cells from deoxynivalenol-induced barrier disruption, oxidative stress, inflammation, and NLRP3 inflammasome activation. Pharmacological ERK activation weakened this protection, supporting ERK as a functional signaling target while highlighting the limits of translating an in vitro mechanism directly to animal or human toxicology.

• HyperFluor™ 488 Rabbit Anti-Goat IgG Workflow

  2026-09-02

  Build sensitive goat-primary immunostaining workflows for hypoxia, inflammation, and tissue-injury studies with a green-fluorescent secondary antibody. This guide connects the reference study’s lung and kidney readouts with practical choices for immunofluorescence, Western blotting, flow cytometry, and tissue imaging.

• Methylprednisolone Sodium Succinate Research

  2026-09-02

  Methylprednisolone Sodium Succinate is a synthetic corticosteroid for research on glucocorticoid-regulated inflammation, immune-cell behavior, and apoptosis induction in tumor cells. Product specifications and cited spinal cord injury evidence support defined assay benchmarks, but they do not establish a universal clinical treatment protocol.

• L1023 Anti-Cancer Compound Library for ccRCC

  2026-09-01

  Use the L1023 Anti-Cancer Compound Library to move from broad phenotypic discovery to pathway-aware validation in clear cell renal cell carcinoma. Its pre-dissolved, chemically diverse format supports reproducible high-throughput screening while the PLAC1 study provides a practical model for selecting orthogonal follow-up assays.

• Tiamulin and Psoriasis-Like Dermatitis: Study Insights

  2026-09-01

  A 2022 Journal of Dermatological Science study used high-throughput screening to identify tiamulin fumarate as a functional inhibitor of TNF-α-driven inflammation. In keratinocytes and an imiquimod-induced mouse model, the compound reduced NF-κB and MAPK pathway activity and improved psoriasis-like dermatitis, supporting further investigation while leaving clinical translation unresolved.

• Imaging FXR Condensates in Coronavirus Replication

  2026-08-31

  A translational framework for connecting FXR-driven liquid–liquid phase separation, coronavirus replication-organelle organization, and reproducible fluorescence workflows using an Alexa Fluor 488 conjugated secondary antibody.

• 3X (DYKDDDDK) Peptide for Assay Controls

  2026-08-31

  Learn how 3X (DYKDDDDK) Peptide, SKU A6001, can strengthen recombinant-protein verification around cell viability, proliferation, and cytotoxicity assays without being mistaken for a direct viability reagent. This scenario-based guide covers compatibility, handling, interpretation, and practical vendor-selection criteria.

• Cannabidiol, Orofacial Pain, and Affective Recovery

  2026-08-30

  This 2026 Brain Research Bulletin study shows that cannabidiol (CBD) can reduce inflammatory pain while also improving pain-associated anxiety-like, depression-like, and cognitive changes in mice. Its main contribution is a multi-level mechanism linking peripheral CB2 signaling, central CB1-dependent endocannabinoid responses, and serotonin dynamics in the central amygdala.

• Rotigotine hydrochloride in Parkinson’s Research

  2026-08-29

  Build more informative dopaminergic signaling experiments with Rotigotine hydrochloride, from SH-SY5Y neuroprotection screens to formulation-enabled nose-to-brain studies. The workflow separates free-compound pharmacology from chitosan nanoparticle delivery so motor, biochemical, uptake, and safety readouts remain interpretable.

• SERCA–ER Stress Drives Hematopoietic Stem Cell Mobilization

  2026-08-28

  The 2025 study by Li, Xu, and Huang identifies SERCA-mediated endoplasmic reticulum stress as a regulator of hematopoietic stem cell mobilization. Using BHQ, in vivo mobilization assays, genetic knockdown, flow cytometry, qRT-PCR, and western blotting, the authors connect SERCA inhibition to the CaMKII–STAT3–CXCR4 axis and reduced CXCR4 surface expression.

• CFDA SE Cell Tracer Kit: Practical Guide

  2026-08-28

  The CFDA SE Cell Tracer Kit provides stable fluorescent labeling for live-cell lineage tracing, proliferation analysis, and longitudinal tracking. It is appropriate when a persistent covalent label is needed, but not when reversible, very short-term, or strictly physiological real-time labeling is required.

8506 records 1/568 page Next 12345 下5页 Last page